McNeil running ads on product withdrawal
FORT WASHINGTON, Pa. As part of its voluntary recall of several nonprescription products marketed toward infant use, McNeil Consumer Healthcare is today running an advertisement in several consumer daily newspapers.
“The cough-and-cold season is here, and we have important information to share about infants’ and children’s cough-and-cold medicines,” the ad starts, noting that while the medicines are generally recognized as safe and effective when used as directed, “we have become aware of rare instances of misuse leading to accidental overdose, especially in children under the age of 2.”
“This voluntary action by McNeil Consumer Healthcare is based on the company’s long-standing commitment to the appropriate use of medications by parents and physicians,” stated Ashley McEvoy, president of McNeil Consumer Healthcare early Thursday morning. “McNeil Consumer Healthcare is committed to providing parents with safe and effective over-the-counter medications that treat their child’s cough-and-cold symptoms. In addition to taking this voluntary action, McNeil Consumer Healthcare, along with our industry partners, supports the Consumer Healthcare Products Association recommendations that were recently submitted to the Food and Drug Administration. These recommendations include label changes to OTC cough-and-cold medicines advising ‘do not use’ in children under 2 years of age. Our voluntary action in removing [these] products from the market is consistent with these recommendations.”
Council for Responsible Nutrition announces winners of CRN Apple Awards
WASHINGTON The Council for Responsible Nutrition on Thursday recognized Mark Blumenthal of the American Botanical Council, Randi Neiner of the Shaklee Corporation, and Carolyn Sabatini of Pharmavite with CRN Apple Awards, an award denoting a long-term commitment and service to both CRN and the dietary supplement industry.
Blumenthal is the founder and executive director of ABC, a nonprofit research and education organization focusing on the responsible use of herbs and medicinal plants.
Neiner works as the director of market research for the Shaklee Corporation where she is responsible for managing competitive intelligence reporting and delivering relevant and actionable research results.
And Sabatini, a 17-year Pharmavite veteran, is the director of government and corporate relations.
Study suggests soy protien may help reduce risk of prostate cancer
ST. LOUIS A study published in the Oct. 1 Journal of Nutrition suggests consumption of soy protein may play a role in reducing the risk of prostate cancer.
“The intent of the study was to evaluate the effects of consuming soy protein on elimination of estrogen metabolites in the urine of men at a high risk for prostate cancer,” stated Mindy Kurzer, lead author of the study and a professor in the Department of Food Science and Nutrition at the University of Minnesota. “After taking biopsies of prostate tissue, androgen receptors were reduced in the prostate, which is consistent with a reduced risk of prostate cancer. In addition, significantly fewer of the men who consumed soy protein progressed to cancer by the end of the six-month study. We are encouraged by the results, but more studies must be performed.”